News

The SOLX Gold Micro-Shunt (GMS, OccuLogix) is a novel approach to treating increased IOP in patients with open-angle glaucoma that does not respond to other therapies and is a good alternative to trabeculectomy, according to Shlomo Melamed, MD, an investigator based in Tel Aviv, Israel.

Marcelo V. Netto, MD, received the annual Troutman Award this year for his paper describing the findings from wavefront analysis in a population of normal refractive surgery patients.

Although the FDA considers autoimmune diseases a contraindication for LASIK regardless of disease severity, a retrospective study suggests that the surgery may be appropriate in patients with well-controlled or inactive disease, said Ronald J. Smith, MD, MPH, of Beverly Hills.

Ranibizumab (Lucentis, Genentech) for treatment of neovascular age-related macular degeneration (AMD) was shown to prevent moderate vision loss over 24 months and to result in improved vision in some patients in the MARINA Study, according to Joan Miller, MD, who reported the results during Retina Subspecialty Day.

Although the FDA considers autoimmune diseases a contraindication for LASIK regardless of disease severity, a retrospective study suggests that the surgery may be appropriate in patients with well-controlled or inactive disease, said Ronald J. Smith, MD, MPH, of Beverly Hills.

Although almost half of all patients who undergo LASIK report dry eye symptoms, there is no real evidence that the refractive procedure causes chronic dry eye, according to James P. McCulley, MD, FACS, UT Southwestern Medical Center, Fort Worth.

The long-term results of the multicenter Age-Related Eye Disease Study (AREDS) indicated that the beneficial effect of treatment with antioxidants and zinc with copper persisted 10 years after the AREDS 1 trial ended, said Emily Chew, MD.

Pellucid marginal degeneration is a subtle condition that could lead to corneal ectasia following laser eye surgery. Although it is atypical and rare, clinicians should learn how to identify pellucid and screen patients for it preoperatively, said Yaron S. Rabinowitz, MD, director of ophthalmology research, Cedars Sinai Medical Center, Los Angeles.

A world-renowned authority on the role of nutrition and lifestyle in the prevention of disease will deliver the Manus C. Kraff Lecture on Science and Medicine at the 2006 Symposium of the American Society of Cataract and Refractive Surgery in April.

Prevent Blindness America (PBA), the nation's oldest and largest non-profit eye health and safety organization, is beginning its application process for the 2007 Eyes on Capitol Hill campaign. This event is designed to allow those affected by real-life vision issues an opportunity to discuss their experiences with their government representatives. The event will begin Feb. 28 in Washington, DC, with discussions on federal funding efforts for vision programs and research and seminars on how participants can become effective advocates in their own communities. The following day, participants will make office visits with congressional members.

The annual American Society of Cata-ract and Refractive Surgery (ASCRS) survey on trends in refractive surgery was expanded this year to include other refractive surgery-related topics. Stephen Wexler, MD, provided the highlights of the survey at this year's annual meeting.

Elegance in motion

When Ming Wang, MD, PhD, is dancing, he is truly living. The Nashville corneal and LASIK surgeon followed a long road to the ballroom dance floor and, today, the Chinese-born doctor is a competitive dancer and encourages others to appreciate the fine arts of music and dance.

Albany, NY-Multicenter data indicate that the Dohlman-Doane type I (Boston) keratoprosthesis is a viable option for visual rehabilitation in eyes in which multiple penetrating keratoplasties have failed or that have a poor prognosis for primary keratoplasty, said Mich?l W. Belin, MD.

Los Angeles-The rates of infection after cataract surgery can be reduced by a meticulous approach to controlling the microbes on the ocular surface and in the eye. The use of fourth-generation fluoroquinolones can better control the microorganisms that have grown resistant to previous generations of the drugs.